People of color face worse outcomes, have lower likelihood of being diagnosed early, receiving surgery

Lung cancer screening at the state level does not correlate with lung cancer burden

Interim analysis shows risk for disease progression or death lower for first-line therapy with lorlatinib versus crizotinib

Guidelines reduce postoperative opioid prescribing but may result in inadequate pain control for some

Use of ACE-I/ARB versus nonuse linked to lower mortality for those hospitalized with flu, pneumonia